1. NOACs in Clinical Practice: Are They All the Same?

3. 10 Years of NOACs

4. Efficacy and Safety of NOACs

5. VTE Is a Leading Cause of Death Worldwide

6. Evidence Base for NOAC Efficacy and Safety in VTE

7. Clinical Implications of Evidence Base

8. Risk of AF Rises With Age

9. AF-Related Strokes Are More Devastating

10. Stroke Prevention in AF

11. XANTUS Major Outcomes

12. XANTUS STUDY Persistence

13. NOACs in ACS, PCI, Cancer-Related VTE, HF

14. APEX: Betrixaban Prophylaxis of VTE in Acute Illness

15. COMPASS

16. COMPASS: CAD and PAD Groups

17. A Paradigm Shift?

18. Decision Making About NOAC Selection

19. Dosing and Administration Considerations

20. Reversal Agents

21. Summary

22. Abbreviations

23. Abbreviations (cont)

24. Website References